Skip to main content
. 2023 Nov 10;4:1296409. doi: 10.3389/fragi.2023.1296409

TABLE 1.

Clinical findings in individuals presenting RTS spectrum harboring variants in RECQL4 (data from our group, not published), ANAPC1, CRIPT and DNA2. Symptoms marked in green are observed in >50% of patients harboring mutations in any of the four genes, while findings marked in orange are gene-specific phenotypes seen in >50% of patients with mutations in only one of the four genes.

RECQL4 ANAPC1 CRIPT DNA2
No of individuals/families 43/39 11/8 6/6 8/7
Gender 23F/20M 5F/6M 2F/4M 3F/5M
Age range 16 m—39 yo NA 70 days—11 yo 2–18 yo
Anthropometric measurements
Short stature (prenatal) 34/43 7/11 (0/1) 6/6 7/7 (6/7)
Z-score range NR NR −2.89 to −5,3 −5,64 to −8,77
Microcephaly NR NR 5/6 6/7
Z-score range −1.75 to—5.49
Ophthalmologic findings
Cataracts 0/26 10/10 (juvenile) 1/6 7/7 (6/7 congenital)
Retinal/optic nerve anomalies 0/23 - 4/6 1/7
Microphthalmia 0/23 1/11 NR 4/7
Corneal opacity 0/23 - NR 5/7
Ectodermal findings
Poikiloderma (generalized) 41/43 11/11 4/4 7/7 (7)
Sparse hair/eyebrows and/or eyelashes 29/43 10/11 5/5 7/7
Dystrophic/small nails 4/7 5/11 2/3 6/7
Skeletal Findings
Osteopenia/metaphyseal striations or irregular, wide metaphysis 7/23 2/5 6/6 2/3
Short metacarpals/phalanges Short hands and/or feet (7/12) 2/5 5/6 4/4
Radial-ray defects 14/40 - 1/6 (proximally placed thumb) 0/7
Axial abnormalities 1/14 NR 6/6—scoliosis 2/2 mild platyspondyly
2/6 platyspondyly
Endocrine anomalies
Growth hormone deficiency (GH therapy) NR 5/10 (6) - 6/6 (5)
Hypothyroidism NR 2/10 - 5/6
Genital anomalies
Cryptorchidism NR 5/5 1/4 3/4M
Micropenis 0/1 1/5 - 4/4M
Neurological findings
Developmental delay/intellectual disability 4/27 2/10 6/6 2/7
Seizures NR NR 4/6 0/7
Other
Recurrent pulmonary infections NR 3/10 (otitis media) 6/6 (pulmonary) 0/7
Cancer (type) 8/43 (6 osteosarcoma +2 skin cancer) 0/10 0/6 0/7
Death in childhood (cause) 1/43 (NR) 0/10 1/6 (pneumonia) 0/7
References Cabral et al. (2008), Siitonen et al. (2009), Piard et al. (2015), Suter et al. (2016), Wang et al. (2018), Colombo et al. (2018), Zhang et al. (2021) Ajeawung et al. (2019), Zirn et al. (2021) Shaheen et al. (2014), Leduc et al. (2016), Akalin et al. (2023), Averdunk et al. (2023) Di Lazzaro Filho et al. (2023)